Keppler Dietrich
German Cancer Research Center, Heidelberg, Germany.
Handb Exp Pharmacol. 2011(201):299-323. doi: 10.1007/978-3-642-14541-4_8.
The nine multidrug resistance proteins (MRPs) represent the major part of the 12 members of the MRP/CFTR subfamily belonging to the 48 human ATP-binding cassette (ABC) transporters. Cloning, functional characterization, and cellular localization of most MRP subfamily members have identified them as ATP-dependent efflux pumps with a broad substrate specificity for the transport of endogenous and xenobiotic anionic substances localized in cellular plasma membranes. Prototypic substrates include glutathione conjugates such as leukotriene C(4) for MRP1, MRP2, and MRP4, bilirubin glucuronosides for MRP2 and MRP3, and cyclic AMP and cyclic GMP for MRP4, MRP5, and MRP8. Reduced glutathione (GSH), present in living cells at millimolar concentrations, modifies the substrate specificities of several MRPs, as exemplified by the cotransport of vincristine with GSH by MRP1, or by the cotransport of GSH with bile acids or of GSH with leukotriene B(4) by MRP4.The role of MRP subfamily members in pathophysiology may be illustrated by the MRP-mediated release of proinflammatory and immunomodulatory mediators such as leukotrienes and prostanoids. Pathophysiological consequences of many genetic variants leading to a lack of functional MRP protein in the plasma membrane are observed in the hereditary MRP2 deficiency associated with conjugated hyperbilirubinemia in Dubin-Johnson syndrome, in pseudoxanthoma elasticum due to mutations in the MRP6 (ABCC6) gene, or in the type of human earwax and osmidrosis determined by single nucleotide polymorphisms in the MRP8 (ABCC8) gene. The hepatobiliary and renal elimination of many drugs and their metabolites is mediated by MRP2 in the hepatocyte canalicular membrane and by MRP4 as well as MRP2 in the luminal membrane of kidney proximal tubules. Therefore, inhibition of these efflux pumps affects pharmacokinetics, unless compensated by other ATP-dependent efflux pumps with overlapping substrate specificities.
9种多药耐药蛋白(MRP)是MRP/CFTR亚家族12个成员中的主要部分,该亚家族属于48种人类ATP结合盒(ABC)转运蛋白。大多数MRP亚家族成员的克隆、功能特性及细胞定位研究已确定它们为ATP依赖性外排泵,对位于细胞质膜中的内源性和外源性阴离子物质具有广泛的底物特异性。典型底物包括:MRP1、MRP2和MRP4的谷胱甘肽共轭物,如白三烯C4;MRP2和MRP3的胆红素葡糖苷酸;MRP4、MRP5和MRP8的环磷酸腺苷(cAMP)和环磷酸鸟苷(cGMP)。毫摩尔浓度的还原型谷胱甘肽(GSH)存在于活细胞中,它可改变几种MRP的底物特异性,例如MRP1介导长春新碱与GSH的共转运,或者MRP4介导GSH与胆汁酸或GSH与白三烯B4的共转运。MRP亚家族成员在病理生理学中的作用可通过MRP介导的促炎和免疫调节介质(如白三烯和前列腺素)的释放来说明。在与杜宾-约翰逊综合征中结合型高胆红素血症相关的遗传性MRP2缺乏症、由于MRP6(ABCC6)基因突变导致的弹性假黄瘤,或由MRP8(ABCC8)基因中的单核苷酸多态性决定的人类耳垢类型和腋臭中,都观察到了许多导致质膜中功能性MRP蛋白缺乏的基因变异的病理生理后果。许多药物及其代谢产物的肝胆和肾脏清除是由肝细胞胆小管膜中的MRP2以及肾近端小管腔膜中的MRP4和MRP2介导的。因此,抑制这些外排泵会影响药代动力学,除非有其他具有重叠底物特异性的ATP依赖性外排泵进行代偿。